Pharmafile Logo
Pharmafocus logo
Advanced Search

Pharma manufacturing news in brief

May 31, 2011
Manufacturing and Production Aurobindo Pharma, Gallus, Lonza, ProMetic, Unigene

This week’s round-up of pharmaceutical manufacturing news includes new contracts for ProMetic and Unigene, plus facility updates from Aurobindo, Gallus …

News

Bayer wields the axe at Emeryville plant

May 31, 2011
Manufacturing and Production Bayer, Emeryville, MS

Bayer Healthcare says it will cut 540 jobs at a production facility in Emeryville, California, next year after shifting production …

News
Pharmaceutical pill manufacturing

Quality by Design – the new manufacturing paradigm

May 31, 2011
Manufacturing and Production Quality by Design, pharma manufacturing

Pharmaceutical manufacturing currently operates using processes that are widely seen as inefficient, inflexible and outdated. In the current system of …

Feature
Pfizer

Pfizer simplifies contract research with Parexel and Icon

May 27, 2011
Research and Development ICON, Parexel, Pfizer, cros

Parexel and Icon have been chosen as Pfizer’s two long-term partners, in a move by the US pharma company to …

News

Clegg calls for further delay to Health Bill

May 27, 2011
Health and Social Care Bill, NHS reforms

The government should amend its NHS reform plans and then allow them to be scrutinised further by MPs, the Deputy …

News
Blog footer

Digital Pharma: Roche launches online warfarin training for patients

May 27, 2011
Medical Communications Digital Pharma blog, Roche, anticoagulant, warfarin

Roche has launched an online training tool to help UK patients on long-term warfarin learn about anticoagulation self-monitoring. The CoaguChek …

News

J&J aims for Japanese pharma expansion

May 27, 2011
Research and Development, Sales and Marketing J&J, JJ

Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …

News

Bayer contraceptive advert breaches Code of Practice

May 27, 2011
Medical Communications ABPI Code of Practice, Bayer, Multaq, Sanofi, Yasmin

Bayer Healthcare has been singled out for “particular censure” by the PMCPA, the body which regulates the ABPI Code of …

News

Chandler Chicco wins award for work on Botox migraine launch

May 27, 2011
Medical Communications Chandler Chicco, awards, medical communications

Chandler Chicco Agency has won an award for its work on the launch of Botox’s chronic migraine indication in the …

News

Digital Pharma: More painful progress for NHS electronic records

May 26, 2011
Medical Communications Digital Pharma blog, IT, NHS, electronic patient records

The NHS’ plans for electronic patient records are in tatters, dogged by missed deadlines, poor value for money and a …

News
Jim Easton

Pharma faces ‘trench warfare’ with NHS

May 26, 2011
Sales and Marketing Cost cutting, NHS, prescribing

The competing interests of the NHS and the pharma industry could end in trench warfare, a leading NHS figure has …

News

BMA calls for major amendments to Health Bill

May 26, 2011
Health and Social Care Bill, NHS reforms

The BMA says the government should withdraw its plans for health reform completely and go back to the drawing board. …

News

British biotech: rebuilding momentum

May 26, 2011
Research and Development UK, biotech, biotech funding

Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …

Feature

NICE to appraise hep C drugs Victrelis and telaprevir

May 26, 2011
Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir

NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …

News

GSK’s Trobalt launched in UK

May 25, 2011
Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine

GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …

News

Elan signs $20m research deal with Proteostasis

May 25, 2011
Research and Development Elan, Proteostasis, neurodegenerative diseases

Elan Corporation has signed a deal with US small molecule drug specialist Proteostasis Therapeutics to develop products for conditions such …

News

Eisai extends neuroscience partnership with UCL

May 25, 2011
Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases

Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …

News

Contract research news in brief

May 25, 2011
Research and Development contract research, contract research news

Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …

News

Mark Duckham joins Adventis Health

May 25, 2011
Medical Communications appointment, medical communications

Adventis Health has appointed Mark Duckham to the newly-created role of client services director. In his new position Mark will …

Appointment
Roche's MabThera’s (rituximab)

NICE U-turn on Roche’s MabThera

May 25, 2011
Sales and Marketing MabThera, NICE, Roche

NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026